{
    "root": "361f9f34-f186-da49-e063-6394a90a3d51",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Gabapentin",
    "value": "20250527",
    "ingredients": [
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "XYLITOL",
            "code": "VCQ006KQ1E"
        },
        {
            "name": "GABAPENTIN",
            "code": "6CW7F3G59X"
        }
    ],
    "indications": "gabapentin oral solution indicated : management postherpetic neuralgia adults adjunctive therapy treatment partial onset seizures , without secondary generalization , adults pediatric patients 3 years older epilepsy",
    "contraindications": "•postherpetic neuralgia ( 2.1 ) •dose titrated needed dose 1800 mg/day •day 1 : single 300 mg dose •day 2 : 600 mg/day ( i.e . , 300 mg two times day ) •day 3 : 900 mg/day ( i.e . , 300 mg three times day ) •epilepsy partial onset seizures ( 2.2 ) •patients 12 years age older : starting dose 300 mg three times daily ; may titrated 600 mg three times daily . •patients 3 11 years age : starting dose range 10 15 mg/kg/day , given three divided doses ; recommended dose patients 3 4 years age 40 mg/kg/day , given three divided doses ; recommended dose patients 5 11 years age 25 35 mg/kg/day , given three divided doses . recommended dose reached upward titration period approximately 3 days •dose adjusted patients reduced renal function ( 2.3 , 2.4 )",
    "warningsAndPrecautions": "gabapentin oral solution supplied follows : 250 mg per 5 ml oral solution : clear colorless slightly yellow solution ; 5 ml oral solution contains 250 mg gabapentin ; available : bottles containing 470 ml : ndc 42192-608-16 ndc 17856-0600-02 gabapentin 300mg/6ml - 6 ml cup 72 ct ud * refrigerated ndc 17856-0600-01 gabapentin 250mg/5ml - 5 ml cup 72 ct ud * refrigerated ndc 17856-0600-03 gabapentin 100mg/2ml - 2 ml syringe 120 ct ud * refrigerated",
    "adverseReactions": "gabapentin oral solution contraindicated patients demonstrated hypersensitivity ingredients .",
    "indications_original": "Gabapentin Oral Solution is indicated for:\n                  \n                     Management of postherpetic neuralgia in adults\n                     Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy",
    "contraindications_original": "•Postherpetic Neuralgia ( 2.1) •Dose can be titrated up as needed to a dose of 1800 mg/day •Day 1: Single 300 mg dose •Day 2: 600 mg/day (i.e., 300 mg two times a day) •Day 3: 900 mg/day (i.e., 300 mg three times a day) •Epilepsy with Partial Onset Seizures ( 2.2) •Patients 12 years of age and older: starting dose is 300 mg three times daily; may be titrated up to 600 mg three times daily. •Patients 3 to 11 years of age: starting dose range is 10 to 15 mg/kg/day, given in three divided doses; recommended dose in patients 3 to 4 years of age is 40 mg/kg/day, given in three divided doses; the recommended dose in patients 5 to 11 years of age is 25 to 35 mg/kg/day, given in three divided doses. The recommended dose is reached by upward titration over a period of approximately 3 days •Dose should be adjusted in patients with reduced renal function ( 2.3, 2.4)",
    "warningsAndPrecautions_original": "Gabapentin Oral Solution is supplied as follows:\n                  250 mg per 5 mL oral solution:\n                  \n                     Clear colorless to slightly yellow solution; each 5 mL of oral solution contains 250 mg of gabapentin; available in: \n     Bottles containing 470 mL: NDC 42192-608-16\n  \n                  \n                  NDC 17856-0600-02 GABAPENTIN 300MG/6ML - 6 ML CUP 72 ct UD *REFRIGERATED\n                  NDC 17856-0600-01 GABAPENTIN 250MG/5ML - 5 ML CUP 72 ct UD * REFRIGERATED\n                  NDC 17856-0600-03 GABAPENTIN 100MG/2ML - 2 ML SYRINGE 120 ct UD * REFRIGERATED",
    "adverseReactions_original": "Gabapentin Oral Solution is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients."
}